173 related articles for article (PubMed ID: 23696891)
1. CD137 is induced by the CD40 signal on chronic lymphocytic leukemia B cells and transduces the survival signal via NF-κB activation.
Nakaima Y; Watanabe K; Koyama T; Miura O; Fukuda T
PLoS One; 2013; 8(5):e64425. PubMed ID: 23696891
[TBL] [Abstract][Full Text] [Related]
2. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ
J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675
[TBL] [Abstract][Full Text] [Related]
3. Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells.
Dicker F; Kater AP; Fukuda T; Kipps TJ
Blood; 2005 Apr; 105(8):3193-8. PubMed ID: 15339846
[TBL] [Abstract][Full Text] [Related]
4. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.
Tromp JM; Tonino SH; Elias JA; Jaspers A; Luijks DM; Kater AP; van Lier RA; van Oers MH; Eldering E
Oncogene; 2010 Sep; 29(36):5071-82. PubMed ID: 20581863
[TBL] [Abstract][Full Text] [Related]
5. CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis.
Mineva ND; Rothstein TL; Meyers JA; Lerner A; Sonenshein GE
J Biol Chem; 2007 Jun; 282(24):17475-85. PubMed ID: 17446175
[TBL] [Abstract][Full Text] [Related]
6. Aberrant CD40-induced NF-κB activation in human lupus B lymphocytes.
Zhang W; Shi Q; Xu X; Chen H; Lin W; Zhang F; Zeng X; Zhang X; Ba D; He W
PLoS One; 2012; 7(8):e41644. PubMed ID: 22952582
[TBL] [Abstract][Full Text] [Related]
7. CD40 ligand in CLL pathogenesis and therapy.
Schattner EJ
Leuk Lymphoma; 2000 May; 37(5-6):461-72. PubMed ID: 11042507
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Bcl-XL by non-canonical NF-κB in the context of CD40-induced drug resistance in CLL.
Haselager M; Thijssen R; West C; Young L; Van Kampen R; Willmore E; Mackay S; Kater A; Eldering E
Cell Death Differ; 2021 May; 28(5):1658-1668. PubMed ID: 33495554
[TBL] [Abstract][Full Text] [Related]
9. CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL.
Travert M; Ame-Thomas P; Pangault C; Morizot A; Micheau O; Semana G; Lamy T; Fest T; Tarte K; Guillaudeux T
J Immunol; 2008 Jul; 181(2):1001-11. PubMed ID: 18606651
[TBL] [Abstract][Full Text] [Related]
10. CD40 regulates the processing of NF-kappaB2 p100 to p52.
Coope HJ; Atkinson PG; Huhse B; Belich M; Janzen J; Holman MJ; Klaus GG; Johnston LH; Ley SC
EMBO J; 2002 Oct; 21(20):5375-85. PubMed ID: 12374738
[TBL] [Abstract][Full Text] [Related]
11. CD40 Signaling in Graves Disease Is Mediated Through Canonical and Noncanonical Thyroidal Nuclear Factor κB Activation.
Lee HJ; Lombardi A; Stefan M; Li CW; Inabnet WB; Owen RP; Concepcion E; Tomer Y
Endocrinology; 2017 Feb; 158(2):410-418. PubMed ID: 27929668
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of proliferation and induction of apoptosis in multiple myeloma cell lines by CD137 ligand signaling.
Gullo C; Koh LK; Pang WL; Ho KT; Tan SH; Schwarz H
PLoS One; 2010 May; 5(5):e10845. PubMed ID: 20520765
[TBL] [Abstract][Full Text] [Related]
13. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
14. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha.
Nishio M; Endo T; Tsukada N; Ohata J; Kitada S; Reed JC; Zvaifler NJ; Kipps TJ
Blood; 2005 Aug; 106(3):1012-20. PubMed ID: 15860672
[TBL] [Abstract][Full Text] [Related]
15. Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents.
Paiva C; Godbersen JC; Berger A; Brown JR; Danilov AV
Cell Death Dis; 2015 Jul; 6(7):e1807. PubMed ID: 26158513
[TBL] [Abstract][Full Text] [Related]
16. Regulation of tumor necrosis factor-alpha expression by CD40 ligation in BV-2 microglial cells.
Jana M; Dasgupta S; Liu X; Pahan K
J Neurochem; 2002 Jan; 80(1):197-206. PubMed ID: 11796758
[TBL] [Abstract][Full Text] [Related]
17. Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway.
Lapalombella R; Andritsos L; Liu Q; May SE; Browning R; Pham LV; Blum KA; Blum W; Ramanunni A; Raymond CA; Smith LL; Lehman A; Mo X; Jarjoura D; Chen CS; Ford R; Rader C; Muthusamy N; Johnson AJ; Byrd JC
Blood; 2010 Apr; 115(13):2619-29. PubMed ID: 19965642
[TBL] [Abstract][Full Text] [Related]
18. Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cells.
Glorieux C; Huang P
Cancer Commun (Lond); 2019 Jul; 39(1):41. PubMed ID: 31288851
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells.
Ranheim EA; Cantwell MJ; Kipps TJ
Blood; 1995 Jun; 85(12):3556-65. PubMed ID: 7540066
[TBL] [Abstract][Full Text] [Related]
20. Role of tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) in distinct and overlapping CD40 and TNF receptor 2/CD120b-mediated B lymphocyte activation.
Munroe ME; Bishop GA
J Biol Chem; 2004 Dec; 279(51):53222-31. PubMed ID: 15485859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]